Progyny’s premarket value rises 5.8% on improved 4Q forecast

Investing.com — Progyny (NASDAQ:), a company specializing in fertility benefits management, reported a 5.8% increase in its premarket value after indicating that its fourth-quarter results will marginally surpass the forecast previously provided.

Progyny’s CEO, Pete Anevski, expressed satisfaction with the company’s performance in the fourth quarter. He stated that member activity had maintained a positive trend in comparison to their earlier projections.

In the company’s official statement, Anevski further revealed that they now anticipate the fourth-quarter results for revenue, net income, and adjusted Ebitda to exceed the ranges they had initially provided in November.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.